These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34437720)

  • 1. Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.
    Khan AH; Reaney M; Guillemin I; Nelson L; Qin S; Kamat S; Mannent L; Amin N; Whalley D; Hopkins C
    Laryngoscope; 2022 May; 132(5):933-941. PubMed ID: 34437720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
    Hopkins C; Mullol J; Khan AH; Lee SE; Wagenmann M; Hellings P; Fokkens W; Msihid J; Nair R; Kamat S; Nash S; Radwan A; Jacob-Nara JA; Deniz Y; Rowe PJ
    Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1173-1182. PubMed ID: 38156522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
    Lee SE; Hopkins C; Mullol J; Msihid J; Guillemin I; Amin N; Mannent LP; Li Y; Siddiqui S; Chuang CC; Kamat S; Khan AH
    Allergy; 2022 Jul; 77(7):2211-2221. PubMed ID: 35034364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps.
    Dharmarajan H; Falade O; Lee SE; Wang EW
    Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of dupilumab on chronic rhinosinusitis with nasal polyps and concomitant asthma in biologic-naive and biologic-pretreated patients.
    Domínguez-Sosa MS; Cabrera-Ramírez MS; Marrero-Ramos MDC; Dávila-Quintana D; Cabrera-López C; González Cuervo H; Benítez Del Rosario JJ; Carrillo-Díaz T
    Ann Med; 2024 Dec; 56(1):2411018. PubMed ID: 39364704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps.
    Riva G; Garetto M; Borgione M; Piazza F; Prizio C; Dellea D; Albera A; Canale A; Pecorari G
    Am J Otolaryngol; 2024; 45(4):104310. PubMed ID: 38677148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Real-World Study Long-Term Clinical Results Using Dupilumab for Chronic Rhinosinusitis With Polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241278659. PubMed ID: 39345032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
    Laidlaw TM; Bachert C; Amin N; Desrosiers M; Hellings PW; Mullol J; Maspero JF; Gevaert P; Zhang M; Mao X; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    Ann Allergy Asthma Immunol; 2021 May; 126(5):584-592.e1. PubMed ID: 33465455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
    Han JK; Bachert C; Lee SE; Hopkins C; Heffler E; Hellings PW; Peters AT; Kamat S; Whalley D; Qin S; Nelson L; Siddiqui S; Khan AH; Li Y; Mannent LP; Guillemin I; Chuang CC
    Laryngoscope; 2022 Feb; 132(2):265-271. PubMed ID: 34850966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
    Mauthe T; Meerwein CM; Ryser FS; Brà Hlmann C; Yalamanoglu A; Steiner UC; Soyka MB
    Rhinology; 2024 Aug; 62(4):496-505. PubMed ID: 38949841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps.
    Kilty SJ; Lasso A
    J Otolaryngol Head Neck Surg; 2022 Apr; 51(1):17. PubMed ID: 35468866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensibility, specificity, and accuracy of the Sinonasal Outcome Test 8 (SNOT-8) in patients with chronic rhinosinusitis (CRS): a cross-sectional cohort study.
    La Mantia I; Ragusa M; Grigaliute E; Cocuzza S; Radulesco T; Calvo-Henriquez C; Saibene AM; Riela PM; Lechien JR; Fakhry N; Michel J; Maniaci A
    Eur Arch Otorhinolaryngol; 2023 Jul; 280(7):3259-3264. PubMed ID: 36705726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of the effectiveness of azoximer bromide and surgery on the quality of the life of patients with chronic rhinosinusitis without nasal polyps].
    Svistushkin VM; Nikiforova GN; Dekhanov AS; Nikiforova AN
    Vestn Otorinolaringol; 2024; 89(2):46-51. PubMed ID: 38805463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Overweight on Response to Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps.
    Habenbacher M; Moser U; Abaira A; Tomazic PV; Kiss P; Holzmeister C; Pock J; Walla K; Lang A; Andrianakis A
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid asthma in patients with chronic rhinosinusitis with nasal polyps: did dupilumab make a difference?
    Al-Ahmad M; Ali A; Khalaf M; Alterki A; Rodriguez-Bouza T
    BMC Pulm Med; 2023 Jul; 23(1):266. PubMed ID: 37464395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).
    Riedl D; Dejaco D; Steinbichler TB; Innerhofer V; Gottfried T; Bektic-Tadic L; Giotakis AI; Rumpold G; Riechelmann H
    J Psychosom Res; 2021 Jan; 140():110316. PubMed ID: 33271403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
    Peters AT; Wagenmann M; Bernstein JA; Khan AH; Nash S; Jacob-Nara JA; Siddiqui S; Rowe PJ; Deniz Y
    Allergy Asthma Proc; 2023 Jul; 44(4):265-274. PubMed ID: 37480206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.